低温与难治性心脏骤停中低ETCO2和低pH-stat PaCO2相关
该研究纳入131例难治性心脏骤停并评估体外心肺复苏的患者(39例低温,92例非低温),比较入院时ETCO2和PaCO2。低温组ETCO2(p<0.001)和pH-stat PaCO2(p<0.001)显著低于非低温组,alpha-stat PaCO2无显著差异(p=0.15)。alpha-stat法PaCO2-ETCO2梯度低温组大于非低温组(46 mmHg vs 30 mmHg,p=0.007),pH-stat法无显著差异(p=0.10)。温度与ETCO2(p<0.01)和pH-stat PaCO2(p<0.01)正相关,温度每降低1°C,ETCO2降低0.5 mmHg,pH-stat PaCO2降低1.1 mmHg。作者结论认为低温心脏骤停不应使用ETCO2预测结局。
要点
- 低温心脏骤停患者入院时ETCO2显著低于非低温患者(p<0.001)。
- 低温心脏骤停患者入院时pH-stat PaCO2显著低于非低温患者(p<0.001),alpha-stat PaCO2无显著差异(p=0.15)。
- alpha-stat法PaCO2-ETCO2梯度低温组大于非低温组(46 mmHg vs 30 mmHg,p=0.007),pH-stat法无显著差异(p=0.10)。
- 温度每降低1°C,ETCO2降低0.5 mmHg,pH-stat PaCO2降低1.1 mmHg。
- 作者认为低温心脏骤停不应使用ETCO2预测结局。
适用人群与场景
- 难治性心脏骤停并评估体外心肺复苏的患者。
- 低温患者来自波兰、法国和瑞士先前前瞻性收集的数据;非低温心脏骤停患者来自两项法国队列研究。
研究设计与关键结果
- 研究类型为基于前瞻性数据和队列研究的分析,纳入131例心脏骤停患者(39例低温,92例非低温),比较入院时ETCO2和PaCO2。
- 低温组ETCO2显著低于非低温组(p<0.001),pH-stat PaCO2显著低于非低温组(p<0.001),alpha-stat PaCO2无显著差异(p=0.15)。
- alpha-stat法PaCO2-ETCO2梯度低温组大于非低温组(46 mmHg vs 30 mmHg,p=0.007),pH-stat法无显著差异(p=0.10)。
- 温度与ETCO2正相关(p<0.01),与pH-stat PaCO2正相关(p<0.01),与alpha-stat PaCO2无显著相关(p=0.5)。
- 温度每降低1°C,ETCO2降低0.5 mmHg,pH-stat PaCO2降低1.1 mmHg。
- 入院时ETCO2≤10 mmHg的存活者比例:低温组45%(9/25),非低温组12%(2/17)。
证据类型、等级与局限
- 证据类型:基于前瞻性数据和队列研究的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,低温心脏骤停不应使用ETCO2预测结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: The end-tidal carbon dioxide (ETCO2) is frequently measured in cardiac arrest (CA) patients, for management and for predicting survival. Our goal was to study the PaCO2 and ETCO2 in hypothermic cardiac arrest patients.
METHODS: We included patients with refractory CA assessed for extracorporeal cardiopulmonary resuscitation. Hypothermic patients were identified from previously prospectively collected data from Poland, France and Switzerland. The non-hypothermic CA patients were identified from two French cohort studies. The primary parameters of interest were ETCO2 and PaCO2 at hospital admission. We analysed the data according to both alpha-stat and pH-stat strategies.
RESULTS: We included 131 CA patients (39 hypothermic and 92 non-hypothermic). Both ETCO2 (p < 0.001) and pH-stat PaCO2 (p < 0.001) were significantly lower in hypothermic compared to non-hypothermic patients, which was not the case for alpha-stat PaCO2 (p = 0.15). The median PaCO2-ETCO2 gradient was greater for hypothermic compared to non-hypothermic patients when using the alpha-stat method (46 mmHg vs 30 mmHg, p = 0.007), but not when using the pH-stat method (p = 0.10). Temperature was positively correlated with ETCO2 (p < 0.01) and pH-stat PaCO2 (p < 0.01) but not with alpha-stat PaCO2 (p = 0.5). The ETCO2 decreased by 0.5 mmHg and the pH-stat PaCO2 by 1.1 mmHg for every decrease of 1° C of the temperature. The proportion of survivors with an ETCO2 ≤ 10 mmHg at hospital admission was 45% (9/25) for hypothermic and 12% (2/17) for non-hypothermic CA patients.
CONCLUSIONS: Hypothermic CA is associated with a decrease of the ETCO2 and pH-stat PaCO2 compared with non-hypothermic CA. ETCO2 should not be used in hypothermic CA for predicting outcome.
参考来源
- Darocha T, Debaty G, Ageron FX, et al. Hypothermia is associated with a low ETCO2 and low pH-stat PaCO2 in refractory cardiac arrest. Resuscitation. 2022. PMID: 35101599. doi:10.1016/j.resuscitation.2022.01.022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。